Arctic Bioscience is a biotech company developing and commercializing pharmaceutical and nutraceutical products based on the unique properties of bioactive marine compounds. The company’s pharmaceutical business is developing a novel oral treatment for mild-to-moderate psoriasis, a large global market with significant unmet medical need. Arctic Bioscience will offer convenient and cost-efficient pharmaceutical treatment extracted from a natural raw material (herring roe). The nutraceutical business has proven traction in the premium Omega 3 market with global expansion potential in B2C and B2B channels. To support its long-term growth strategy, Arctic Bioscience is integrating its value chain and planning a state-of-the-art manufacturing facility with a proprietary production process to enable large-scale high-quality production. Based in Ørsta on the West Coast of Norway with access to locally sourced herring roe raw material and led by a team with 30+ years of marine extracts experience, Arctic Bioscience is on a mission to empower healthy lives.
